Filing Details
- Accession Number:
- 0000886163-17-000138
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-17 17:14:53
- Reporting Period:
- 2017-11-16
- Accepted Time:
- 2017-11-17 17:14:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1223000 | W John Kozarich | 3911 Sorrento Valley Boulevard, Ste 110 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-11-16 | 5,000 | $141.71 | 35,649 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The reporting person contributed LGND common stock to an exchange fund in exchange for shares of the exchange fund. The LGND common stock was valued at $141.71 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.
Billionaire Hedge Funds
